| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, Republic of China
Arsenic compounds are potent human carcinogens. Accumulated evidence has shown that arsenite-induced cytogenetic alterations are associated with the carcinogenicity of arsenic. Because p53 plays a guarding role in maintaining genome integrity and accuracy of chromosome segregation, the mechanistic effects of arsenite on p53 activation were analyzed. In the present study, arsenite-induced DNA strand breaks were confirmed by alkaline single-cell gel electrophoresis (comet assay) in human fibroblast (HFW) cells. Accompanying the appearance of DNA strand breaks was a significant accumulation of p53 in arsenite-treated HFW cells, as demonstrated by immunoblotting and immunofluorescence techniques. p53 downstream proteins, such as p21 and the human homologue of murine double minute-2, were also significantly induced by arsenite treatment. Cell cycle retardation and G2-M arrest were observed in 5-bromo-2'-deoxyuridine pulse-labeled HFW cells by flow cytometry. Wortmannin, an inhibitor of phosphatidylinositol 3-kinases, inhibited arsenite- or X-ray irradiation-induced p53 accumulation but did not alter UV irradiation- or N-acetyl-Leu-Leu-norleucinal-induced p53 accumulation. p53 phosphorylation on serine 15 was also confirmed by immunoblotting technique in arsenite- and X-ray-treated HFW cells but was not observed in UV- or N-acetyl-Leu-Leu-norleucinal-treated HFW cells. These results suggest the involvement of a phosphatidylinositol 3-kinase-related protein kinase in arsenite-induced p53 accumulation. For confirmation, we demonstrated that arsenite treatment, similar to X-ray irradiation, did not induce p53 accumulation in GM3395 fibroblasts derived from a patient with ataxia telangiectasia. In contrast, UV irradiation did cause p53 accumulation in these cells. Together, these findings infer that arsenite-induced DNA strand breaks may lead to p53 phosphorylation and accumulation through an ataxia telangiectasia mutated-dependent pathway in HFW cells.
This article has been cited by other articles:
|
|
 |
|
  F. T Celino, S. Yamaguchi, C. Miura, and T. Miura Arsenic inhibits in vitro spermatogenesis and induces germ cell apoptosis in Japanese eel (Anguilla japonica) Reproduction, August 1, 2009; 138(2): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Uen, Y.-J. Wang, T.-M. Hsu, M.-H. Chen, H.-Y. Chan, Y.-S. Ho, and S.-Y. Lin Effects of Fungal-derived High Molecular Weight Chitosan on 5-Fluorouracil-induced Adverse Reactions Journal of Bioactive and Compatible Polymers, September 1, 2008; 23(5): 458 - 472. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Yoda, K. Toyoshima, Y. Watanabe, N. Onishi, Y. Hazaka, Y. Tsukuda, J. Tsukada, T. Kondo, Y. Tanaka, and Y. Minami Arsenic Trioxide Augments Chk2/p53-mediated Apoptosis by Inhibiting Oncogenic Wip1 Phosphatase J. Biol. Chem., July 4, 2008; 283(27): 18969 - 18979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, Y. Zhao, L. Li, M. A. McNutt, L. Wu, S. Lu, Y. Yu, W. Zhou, J. Feng, G. Chai, et al. An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of p53/p21Waf1/Cip1 in Response to 5-Aza-2'-deoxycytidine Treatment J. Biol. Chem., February 1, 2008; 283(5): 2564 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Chai, Y.-C. Huang, W.-C. Hung, W.-Y. Kang, and W.-T. Chen Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells Mutagenesis, November 1, 2007; 22(6): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sandoval, M. Morales, R. Tapia, L. del Carmen Alarcon, M. Sordo, P. Ostrosky-Wegman, A. Ortega, and E. Lopez-Bayghen p53 Response to Arsenic Exposure in Epithelial Cells: Protein Kinase B/Akt Involvement Toxicol. Sci., September 1, 2007; 99(1): 126 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Taylor, S. C. McNeely, H. L. Miller, G. M. Lehmann, M. J. McCabe Jr., and J. C. States p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1 J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 142 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Sidhu, R. A. Ponce, M. A. Vredevoogd, X. Yu, E. Gribble, S.-W. Hong, E. Schneider, and E. M. Faustman Cell Cycle Inhibition by Sodium Arsenite in Primary Embryonic Rat Midbrain Neuroepithelial Cells Toxicol. Sci., February 1, 2006; 89(2): 475 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Li, J.-C. Lin, and J.-L. Yang ERK Activation in Arsenite-Treated G1-Enriched CL3 Cells Contributes to Survival, DNA Repair Inhibition, and Micronucleus Formation Toxicol. Sci., January 1, 2006; 89(1): 164 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Wong, M. Fricker, A. Wyttenbach, A. Villunger, E. M. Michalak, A. Strasser, and A. M. Tolkovsky Mutually Exclusive Subsets of BH3-Only Proteins Are Activated by the p53 and c-Jun N-Terminal Kinase/c-Jun Signaling Pathways during Cortical Neuron Apoptosis Induced by Arsenite Mol. Cell. Biol., October 1, 2005; 25(19): 8732 - 8747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nuntharatanapong, K. Chen, P. Sinhaseni, and J. F. Keaney Jr. EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H99 - H107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-C. Lee, I-C. Ho, and T.-C. Lee Oxidative Stress Mediates Sodium Arsenite-Induced Expression of Heme Oxygenase-1, Monocyte Chemoattractant Protein-1, and Interleukin-6 in Vascular Smooth Muscle Cells Toxicol. Sci., May 1, 2005; 85(1): 541 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Bonzo, S. Chen, A. Galijatovic, and R. H. Tukey Arsenite Inhibition of CYP1A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Independent of Cell Cycle Arrest Mol. Pharmacol., April 1, 2005; 67(4): 1247 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-H. Yih, S.-W. Hsueh, W.-S. Luu, T. H. Chiu, and T.-C. Lee Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells Carcinogenesis, January 1, 2005; 26(1): 53 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. U. Kurz, P. Douglas, and S. P. Lees-Miller Doxorubicin Activates ATM-dependent Phosphorylation of Multiple Downstream Targets in Part through the Generation of Reactive Oxygen Species J. Biol. Chem., December 17, 2004; 279(51): 53272 - 53281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lunghi, A. Costanzo, M. Levrero, and A. Bonati Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells Blood, July 15, 2004; 104(2): 519 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Zhang, M. T. Schmitt, and J. L. Mumford Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro Carcinogenesis, November 1, 2003; 24(11): 1811 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-H. Yih and T.-C. Lee Induction of C-Anaphase and Diplochromosome through Dysregulation of Spindle Assembly Checkpoint by Sodium Arsenite in Human Fibroblasts Cancer Res., October 15, 2003; 63(20): 6680 - 6688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Miller Jr., H. M. Schipper, J. S. Lee, J. Singer, and S. Waxman Mechanisms of Action of Arsenic Trioxide Cancer Res., July 15, 2002; 62(14): 3893 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wang, N. Li, X. Wang, M. M. Kim, and B. M. Evers Augmentation of Sodium Butyrate-induced Apoptosis by Phosphatidylinositol 3'-Kinase Inhibition in the KM20 Human Colon Cancer Cell Line Clin. Cancer Res., June 1, 2002; 8(6): 1940 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-H. Yih, K. Peck, and T.-C. Lee Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment Carcinogenesis, May 1, 2002; 23(5): 867 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, W.-Y. Ma, A. Kaji, A. M. Bode, and Z. Dong Requirement of ATM in UVA-induced Signaling and Apoptosis J. Biol. Chem., January 25, 2002; 277(5): 3124 - 3131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Silins, N. Finnberg, A. Stahl, J. Hogberg, and U. Stenius Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat Carcinogenesis, December 1, 2001; 22(12): 2023 - 2031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Menendez, G. Mora, A.M. Salazar, and P. Ostrosky-Wegman ATM status confers sensitivity to arsenic cytotoxic effects Mutagenesis, September 1, 2001; 16(5): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Parra, M. Jardi, M. Koziczak, Y. Nagamine, and P. Munoz-Canoves p53 Phosphorylation at Serine 15 Is Required for Transcriptional Induction of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene by the Alkylating Agent N-Methyl-N'-nitro-N-nitrosoguanidine J. Biol. Chem., September 21, 2001; 276(39): 36303 - 36310. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
